Mannheimia haemolytica growth and leukotoxin production for vaccine manufacturing — A bioprocess review

1Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Mannheimia haemolytica leukotoxin (LKT) is a known cause of bovine respiratory disease (BRD) which results in severe economic losses in the cattle industry (up to USD 1 billion per year in the USA). Vaccines based on LKT offer the most promising measure to contain BRD outbreaks and are already commercially available. However, insufficient LKT yields, predominantly reflecting a lack of knowledge about the LKT expression process, remain a significant engineering problem and further bioprocess optimization is required to increase process efficiency. Most previous investigations have focused on LKT activity and cell growth, but neither of these parameters defines reliable criteria for the improvement of LKT yields. In this article, we review the most important process conditions and operational parameters (temperature, pH, substrate concentration, dissolved oxygen level, medium composition and the presence of metabolites) from a bioprocess engineering perspective, in order to maximize LKT yields.

Cite

CITATION STYLE

APA

Oppermann, T., Busse, N., & Czermak, P. (2017, July 1). Mannheimia haemolytica growth and leukotoxin production for vaccine manufacturing — A bioprocess review. Electronic Journal of Biotechnology. Pontificia Universidad Catolica de Valparaiso. https://doi.org/10.1016/j.ejbt.2017.06.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free